# Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM

> **NCT02301806** · PHASE4 · UNKNOWN · sponsor: **Dokkyo Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** dieting
- **DRUG:** Sitagliptin
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT02301806
- **Lead sponsor:** Dokkyo Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02301806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02301806, "Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02301806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*